Abbott second-generation albumin BCG assay set - Taiwan Registration ad7691e4b471227698a42eeac8678933
Access comprehensive regulatory information for Abbott second-generation albumin BCG assay set in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number ad7691e4b471227698a42eeac8678933 and manufactured by ABBOTT IRELAND DIAGNOSTICS DIVISION. The authorized representative in Taiwan is ABBOTT LABORATORIES SERVICES LLC TAIWAN BRANCH (U.S.A.).
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Product Details
This product is used to quantify albumin in human serum or plasma on the Alinity c System.
A Clinical chemistry and clinical toxicology
A.1035 Albumin Testing System
Input;; QMS/QSD
Dates and Status
Jan 03, 2022
Jan 03, 2027

